{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:23:48Z","timestamp":1761110628474,"version":"3.40.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100002193","name":"Lupus Foundation of America","doi-asserted-by":"publisher","award":["Gary Gilkeson Career Development Award"],"award-info":[{"award-number":["Gary Gilkeson Career Development Award"]}],"id":[{"id":"10.13039\/100002193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24 AR066109","T32 HL094301"],"award-info":[{"award-number":["K24 AR066109","T32 HL094301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["21CDA851511"],"award-info":[{"award-number":["21CDA851511"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-022-05125-0","type":"journal-article","created":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T19:03:33Z","timestamp":1650135813000},"page":"1767-1774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of ECG testing and characteristics among new hydroxychloroquine and chloroquine users within a multi-center tertiary care center"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3760-2737","authenticated-orcid":false,"given":"May Y.","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongshu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Ellrodt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Oakes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Di Carli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha","family":"Tedrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8972-9388","authenticated-orcid":false,"given":"Karen H.","family":"Costenbader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,16]]},"reference":[{"issue":"1","key":"5125_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/acr.23826","volume":"72","author":"C Rempenault","year":"2020","unstructured":"Rempenault C, Combe B, Barnetche T, Gaujoux-Viala C, Lukas C, Morel J, Hua C (2020) Clinical and structural efficacy of hydroxychloroquine in rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken) 72(1):36\u201340. https:\/\/doi.org\/10.1002\/acr.23826","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"5125_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/0961203307086503","volume":"17","author":"A Siso","year":"2008","unstructured":"Siso A, Ramos-Casals M, Bove A, Brito-Zeron P, Soria N, Munoz S, Testi A, Plaza J, Sentis J, Coca A (2008) Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival. Lupus 17(4):281\u2013288. https:\/\/doi.org\/10.1177\/0961203307086503","journal-title":"Lupus"},{"issue":"6","key":"5125_CR3","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/art.24538","volume":"61","author":"Pons-Estel GJ, Alarcon GS, McGwin G, Jr., Danila MI, Zhang J, Bastian HM, Reveille JD, Vila LM, Lumina Study G","year":"2009","unstructured":"Pons-Estel GJ, Alarcon GS, McGwin G, Jr., Danila MI, Zhang J, Bastian HM, Reveille JD, Vila LM, Lumina Study G (2009) Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Rheum 61(6):830\u2013839. https:\/\/doi.org\/10.1002\/art.24538","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5125_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/ard.2008.101766","volume":"69","author":"G Ruiz-Irastorza","year":"2010","unstructured":"Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA (2010) Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 69(1):20\u201328. https:\/\/doi.org\/10.1136\/ard.2008.101766","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5125_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstrom K, Moroni G, Mosca M, Schneider M, Smolen JS, Svenungsson E, Tesar V, Tincani A, Troldborg A, van Vollenhoven R, Wenzel J, Bertsias G, Boumpas DT (2019) 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78(6):736\u2013745. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215089","journal-title":"Ann Rheum Dis"},{"key":"5125_CR6","unstructured":"Meeting WERG (2017) World Health Organization. The cardiotoxicity of antimalarials: Malaria Policy Advisory Committee Meeting. https:\/\/www.who.int\/malaria\/mpac\/mpac-mar2017-erg-cardiotoxicity-report-session2.pdf. Accessed 21 Apr 2020"},{"issue":"21","key":"5125_CR7","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1056\/NEJMoa2019014","volume":"383","author":"AB Cavalcanti","year":"2020","unstructured":"Cavalcanti AB, Zampieri FG, Rosa RG, Azevedo LCP, Veiga VC, Avezum A, Damiani LP, Marcadenti A, Kawano-Dourado L, Lisboa T, Junqueira DLM, de Barros ESPGM, Tramujas L, Abreu-Silva EO, Laranjeira LN, Soares AT, Echenique LS, Pereira AJ, Freitas FGR, Gebara OCE, Dantas VCS, Furtado RHM, Milan EP, Golin NA, Cardoso FF, Maia IS, Hoffmann Filho CR, Kormann APM, Amazonas RB, Bocchi de Oliveira MF, Serpa-Neto A, Falavigna M, Lopes RD, Machado FR, Berwanger O, Coalition Covid-19 Brazil II (2020) Hydroxychloroquine with or without azithromycin in mild-to-moderate covid-19. N Engl J Med 383(21):2041\u20132052. https:\/\/doi.org\/10.1056\/NEJMoa2019014","journal-title":"N Engl J Med"},{"issue":"1","key":"5125_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/annrheumdis-2017-211836","volume":"77","author":"C Rempenault","year":"2018","unstructured":"Rempenault C, Combe B, Barnetche T, Gaujoux-Viala C, Lukas C, Morel J, Hua C (2018) Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis. Ann Rheum Dis 77(1):98\u2013103. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211836","journal-title":"Ann Rheum Dis"},{"key":"5125_CR9","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.2147\/DDDT.S166893","volume":"12","author":"D Liu","year":"2018","unstructured":"Liu D, Li X, Zhang Y, Kwong JS, Li L, Zhang Y, Xu C, Li Q, Sun X, Tian H, Li S (2018) Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis. Drug Des Devel Ther 12:1685\u20131695. https:\/\/doi.org\/10.2147\/DDDT.S166893","journal-title":"Drug Des Devel Ther"},{"issue":"10","key":"5125_CR10","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1161\/CIRCULATIONAHA.108.191096","volume":"119","author":"PM Rautaharju","year":"2009","unstructured":"Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, Deal BJ, Gorgels A, Hancock EW, Josephson M, Kligfield P, Kors JA, Macfarlane P, Mason JW, Mirvis DM, Okin P, Pahlm O, van Herpen G, Wagner GS, Wellens H, American Heart Association E, Arrhythmias Committee CoCC, American College of Cardiology F, Heart Rhythm S (2009) AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation 119(10):e241-250. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.191096","journal-title":"Circulation"},{"issue":"8","key":"5125_CR11","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.109.192704","volume":"121","author":"Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, Philippides GJ, Roden DM, Zareba W, American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology tCoCN, the American College of Cardiology F","year":"2010","unstructured":"Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, Philippides GJ, Roden DM, Zareba W, American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology tCoCN, the American College of Cardiology F (2010) Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation 121(8):1047\u20131060. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192704","journal-title":"Circulation"},{"issue":"6","key":"5125_CR12","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1161\/01.cir.94.6.1471","volume":"94","author":"MD Drici","year":"1996","unstructured":"Drici MD, Burklow TR, Haridasse V, Glazer RI, Woosley RL (1996) Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 94(6):1471\u20131474. https:\/\/doi.org\/10.1161\/01.cir.94.6.1471","journal-title":"Circulation"},{"issue":"2","key":"5125_CR13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0022-3565(24)37435-X","volume":"285","author":"XK Liu","year":"1998","unstructured":"Liu XK, Katchman A, Drici MD, Ebert SN, Ducic I, Morad M, Woosley RL (1998) Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J Pharmacol Exp Ther 285(2):672\u2013679","journal-title":"J Pharmacol Exp Ther"},{"issue":"21","key":"5125_CR14","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1001\/jama.270.21.2590","volume":"270","author":"RR Makkar","year":"1993","unstructured":"Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH (1993) Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 270(21):2590\u20132597. https:\/\/doi.org\/10.1001\/jama.270.21.2590","journal-title":"JAMA"},{"issue":"12","key":"5125_CR15","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/art.41934","volume":"73","author":"J Desmarais","year":"2021","unstructured":"Desmarais J, Rosenbaum JT, Costenbader KH, Ginzler EM, Fett N, Goodman S, O\u2019Dell J, Pineau CA, Schmajuk G, Werth VP, Link MS, Kovacs R (2021) American college of rheumatology white paper on antimalarial cardiac toxicity. Arthritis Rheumatol 73(12):2151\u20132160. https:\/\/doi.org\/10.1002\/art.41934","journal-title":"Arthritis Rheumatol"},{"key":"5125_CR16","unstructured":"Haj-Ali M, Belmont HM (2020) Hydroxychloroquine and QTc prolongation in a cohort of SLE patients [abstract]. Arthritis Rheumatol 72(10)"},{"key":"5125_CR17","unstructured":"Renaldi J, Koumpouras F, Dong MX (2020) Evaluating the risk of QT-prolongation associated with hydroxychloroquine use with and without antidepressants in SLE patients with fibromyalgia [abstract]. Arthritis Rheumatol 72(10)"},{"key":"5125_CR18","unstructured":"Restrepo JF, Escalante A, Battafarano D, Lorenzo C, Del Rincon I (2020) Hydroxychloroquine is not cardiotoxic in patients with rheumatoid arthritis [abstract]. Arthritis Rheumatol 72(10)"},{"key":"5125_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2021.1879368","author":"T Nishiyama","year":"2021","unstructured":"Nishiyama T, Kondo Y, Tsuboi H, Tabuchi D, Sugita T, Okamoto S, Terasaki T, Shimizu M, Honda F, Ohyama A, Kurata I, Yagishita M, Abe S, Takahashi H, Osada A, Hagiwara S, Matsumoto I, Sumida T, Noma H (2021) QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine. Mod Rheumatol. https:\/\/doi.org\/10.1080\/14397595.2021.1879368","journal-title":"Mod Rheumatol"},{"issue":"4","key":"5125_CR20","doi-asserted-by":"publisher","first-page":"380","DOI":"10.4997\/JRCPE.2020.406","volume":"50","author":"M Azharudeen","year":"2020","unstructured":"Azharudeen M, Thabah MM, Satheesh S, Negi VS (2020) QT interval parameters, anti-Ro antibody status, and disease activity in systemic lupus erythematosus. J R Coll Physicians Edinb 50(4):380\u2013386. https:\/\/doi.org\/10.4997\/JRCPE.2020.406","journal-title":"J R Coll Physicians Edinb"},{"issue":"10","key":"5125_CR21","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s40264-018-0689-4","volume":"41","author":"C Chatre","year":"2018","unstructured":"Chatre C, Roubille F, Vernhet H, Jorgensen C, Pers YM (2018) Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature. Drug Saf 41(10):919\u2013931. https:\/\/doi.org\/10.1007\/s40264-018-0689-4","journal-title":"Drug Saf"},{"issue":"2","key":"5125_CR22","first-page":"83","volume":"45","author":"MD Bustos","year":"1994","unstructured":"Bustos MD, Gay F, Diquet B, Thomare P, Warot D (1994) The pharmacokinetics and electrocardiographic effects of chloroquine in healthy subjects. Trop Med Parasitol 45(2):83\u201386","journal-title":"Trop Med Parasitol"},{"issue":"6","key":"5125_CR23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1365-2125.1989.tb03439.x","volume":"27","author":"SE Tett","year":"1989","unstructured":"Tett SE, Cutler DJ, Day RO, Brown KF (1989) Bioavailability of hydroxychloroquine tablets in healthy volunteers. Br J Clin Pharmacol 27(6):771\u2013779. https:\/\/doi.org\/10.1111\/j.1365-2125.1989.tb03439.x","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"5125_CR24","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/art.41121","volume":"72","author":"M Petri","year":"2020","unstructured":"Petri M, Elkhalifa M, Li J, Magder LS, Goldman DW (2020) Hydroxychloroquine blood levels predict hydroxychloroquine retinopathy. Arthritis Rheumatol 72(3):448\u2013453. https:\/\/doi.org\/10.1002\/art.41121","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05125-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-022-05125-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05125-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T11:33:17Z","timestamp":1744198397000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-022-05125-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,16]]},"references-count":24,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["5125"],"URL":"https:\/\/doi.org\/10.1007\/s00296-022-05125-0","relation":{},"ISSN":["1437-160X"],"issn-type":[{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2022,4,16]]},"assertion":[{"value":"10 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. May Choi has received consulting fees from Janssen, Astra Zeneca, and MitogenDx. Dr. Costenbader has consulted for or collaborated on research projects with Janssen, Glaxo Smith Kline, Exagen Diagnostics, Eli Lilly, Merck Serono, Astra Zeneca and Neutrolis (less than $10,000 each). Marcelo DiCarli reports grants from Gilead and Spectrum Dynamics. Usha Tedrow has received teaching honoraria from Biosense Webster, Boston Scientific and Abbott medical, consulting monies from Thermedical Inc. related to a specialized ablation catheter. All other authors have no relevant disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research involves human participants. An Institutional Review Board of Brigham and Women\u2019s Hospital approved all aspects of this study (IRB 2020-P-002154).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}